Orion Oyj (ORINF) Projected to Post Earnings on Thursday
by Doug Wharley · The Cerbat GemOrion Oyj (OTCMKTS:ORINF – Get Free Report) is anticipated to issue its resultson Thursday, April 23rd. Analysts expect the company to announce earnings of $0.6760 per share and revenue of $415.1720 million for the quarter.
Orion Oyj Price Performance
OTCMKTS:ORINF opened at $82.75 on Tuesday. Orion Oyj has a twelve month low of $78.95 and a twelve month high of $82.75. The business has a 50 day moving average price of $80.00 and a two-hundred day moving average price of $80.79.
Orion Oyj Company Profile
Orion Oyj is a Finland-based pharmaceutical and diagnostic products company that develops, manufactures and markets both human and veterinary medicines, diagnostic tests and active pharmaceutical ingredients. With a history dating back to its founding in 1917, the company has evolved into a diversified life science group, offering prescription and over-the-counter products for neurological, respiratory, cardiovascular and urological conditions, among others. Orion’s human pharmaceuticals portfolio includes well-known treatments for Parkinson’s disease, hormone therapy and erectile dysfunction, while its veterinary range addresses animal health needs such as pain management and dermatology.
In its Diagnostics segment, Orion produces laboratory tests and instruments for clinical chemistry and immunoassay applications, focusing on hormone and drug monitoring.